You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-p95 NBS1 (phospho S343) antibody (ab47272)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-p95 NBS1 (phospho S343) antibody
See all p95 NBS1 products (14) ...

Description

Rabbit polyclonal to p95 NBS1 (phospho S343)

Specificity

Detects endogenous levels of p95 NBS1 only when phosphorylated at Serine 343.

Tested applications

WB, ELISAmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthesized phosphopeptide derived from human p95/NBS1 around the phosphorylation site of serine 343 (S-L-SP-Q-G).

Positive control

Jurkat cell extract.

Properties

Form

Liquid

Storage instructions

Store at -20°C. Stable for 12 months at -20°C

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS (without Mg2+ or Ca2+), 150mM Sodium chloride, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Purification notes

The antibody against the non phosphopeptide was removed by chromatography using non phosphopeptide corresponding to the phosphorylation site.

Clonality

Polyclonal

Isotype

IgG

  • Western blot - p95 NBS1 (phospho S343) antibody (ab47272)Western blot - p95 NBS1 (phospho S343) antibody (ab47272) image (enlarge)

  • Western blot - p95 NBS1 (phospho S343) antibody (ab47272)Western blot - p95 NBS1 (phospho S343) antibody (ab47272) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab47272 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Component of the MRE11/RAD50/NBN (MRN complex) which plays a critical role in the cellular response to DNA damage and the maintenance of chromosome integrity. The complex is involved in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity, cell cycle checkpoint control and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11A. RAD50 may be required to bind DNA ends and hold them in close proximity. NBN modulate the DNA damage signal sensing by recruiting PI3/PI4-kinase family members ATM, ATR, and probably DNA-PKcs to the DNA damage sites and activating their functions. It can also recruit MRE11 and RAD50 to the proximity of DSBs by an interaction with the histone H2AX. NBN also functions in telomere length maintenance by generating the 3' overhang which serves as a primer for telomerase dependent telomere elongation. NBN is a major player in the control of intra-S-phase checkpoint and there is some evidence that NBN is involved in G1 and G2 checkpoints. The roles of NBS1/MRN encompass DNA damage sensor, signal transducer, and effector, which enable cells to maintain DNA integrity and genomic stability.

Tissue specificity

Ubiquitous. Expressed at high levels in testis.

Involvement in disease

Defects in NBN are the cause of Nijmegen breakage syndrome (NBS) [MIM:251260]. NBS is an autosomal recessive syndrome characterized by chromosomal instability, radiation sensitivity, microcephaly, growth retardation, immunodeficiency and predisposition to cancer, particularly to lymphoid malignancies.
Defects in NBN are a cause of susceptibility to breast cancer (BC) [MIM:114480]. A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.
Defects in NBN may be associated with aplastic anemia (AA) [MIM:609135]. A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. It is characterized by peripheral pancytopenia and marrow hypoplasia.
Note=Defects in NBN might play a role in the pathogenesis of childhood acute lymphoblastic leukemia (ALL).

Sequence similarities

Contains 1 BRCT domain.
Contains 1 FHA domain.

Domain

The FHA and BRCT domains are likely to have a crucial role for both binding to histone H2AFX and for relocalization of MRE11/RAD50 complex to the vicinity of DNA damage.
The C-terminal domain contains a MRE11-binding site, and this interaction is required for the nuclear localization of the MRN complex.
The EEXXXDDL motif at the C-terminus is required for the interaction with ATM and its recruitment to sites of DNA damage and promote the phosphorylation of ATM substrates, leading to the events of DNA damage response.

Post-translational
modifications

Phosphorylated by ATM in response of ionizing radiation, and such phosphorylation is responsible intra-S phase checkpoint control and telomere maintenance.

Cellular localization

Nucleus. Chromosome > telomere. Localizes to discrete nuclear foci after treatment with genotoxic agents.

Target information above from: UniProt accessionO60934 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • AT V1 antibody
  • AT V2 antibody
  • ATV antibody
  • Cell cycle regulatory protein p95 antibody
  • FLJ10155 antibody
  • MGC87362 antibody
  • NBN antibody
  • NBN_HUMAN antibody
  • NBS 1 antibody
  • NBS antibody
  • NBS1 antibody
  • Nibrin antibody
  • Nijmegen breakage syndrome antibody
  • Nijmegen breakage syndrome protein 1 antibody
  • p95 antibody
see all

Anti-p95 NBS1 (phospho S343) antibody images:

  Western blot - p95 NBS1 (phospho S343) antibody (ab47272)

Western blot - p95 NBS1 (phospho S343) antibody (ab47272)

All lanes : Anti-p95 NBS1 (phospho S343) antibody (ab47272) at 1/500 dilution

Lane 1 : 5-30ug Jurkat cell extract, treated with immunogenic peptide.
Lane 2 : 5-30ug Jurkat cell extract, untreated.

Secondary
Alkaline Phosphatase Goat Anti IgG (H+L)

Predicted band size : 85 kDa

  Western blot - p95 NBS1 (phospho S343) antibody (ab47272)

Western blot - p95 NBS1 (phospho S343) antibody (ab47272)

All lanes : Anti-p95 NBS1 (phospho S343) antibody (ab47272) at 1/500 dilution

Lane 1 : Unirradiated Human lymphoblastoid cell lines from normal individual - Whole cell lysate
Lane 2 : Irradiated Human lymphoblastoid cell lines from normal individual - Whole cell lysate
Lane 3 : Unirradiated Human lymphoblastoid cell lines from classical A-T patient (no ATM kinase expressed) - Whole cell lysate
Lane 4 : Irradiated Human lymphoblastoid cell lines from classical A-T patient (no ATM kinase expressed) - Whole cell lysate

Lysates/proteins at 50 µg per lane.

Secondary
An HRP-conjugated Goat polyclonal to rabbit IgG at 1/3000 dilution

Predicted band size : 85 kDa

This image is courtesy of an anonymous Abreview

See Abreview

References for Anti-p95 NBS1 (phospho S343) antibody (ab47272)

This product has been referenced in:

  • Horton JKet al. Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition. DNA Repair (Amst) 10:225-34 (2011). WB; Human.Read more (PubMed: 21130714) »
  • Reiman Aet al. Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br J Cancer 105:586-91 (2011). WB; Human.Read more (PubMed: 21792198) »

See all 3 publications for this product

Publishing research using ab47272? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"